# Carolyn Y. Ho

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/carolyn-y-ho/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,551 |
| Field | Cardiomyopathy and Myosin Studies |
| h-index | 75 |
| i10-index | 149 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5001038100 |
| ORCID iD | https://orcid.org/0000-0002-7334-7924 |
| Works | 300 |

## Researcher papers

- [Truncations of Titin Causing Dilated Cardiomyopathy](https://scholariq.org/papers/truncations-of-titin-causing-dilated-cardiomyopathy/)
- [Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/mavacamten-for-treatment-of-symptomatic-obstructive-hypertrophic-cardiomyopathy/)
- [Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy](https://scholariq.org/papers/genotype-and-lifetime-burden-of-disease-in-hypertrophic-cardiomyopathy/)
- [Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy](https://scholariq.org/papers/myocardial-fibrosis-as-an-early-manifestation-of-hypertrophic-cardiomyopathy/)
- [Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy](https://scholariq.org/papers/evaluation-of-mavacamten-in-symptomatic-patients-with-nonobstructive/)
- [Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity](https://scholariq.org/papers/common-genetic-variants-and-modifiable-risk-factors-underpin-hypertrophic/)
- [Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry](https://scholariq.org/papers/distinct-subgroups-in-hypertrophic-cardiomyopathy-in-the-nhlbi-hcm-registry/)
- [Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers](https://scholariq.org/papers/long-term-arrhythmic-and-nonarrhythmic-outcomes-of-lamin-a-c-mutation-carriers/)
- [T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy](https://scholariq.org/papers/t1-measurements-identify-extracellular-volume-expansion-in-hypertrophic/)
- [A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy](https://scholariq.org/papers/a-validated-model-for-sudden-cardiac-death-risk-prediction-in-pediatric/)
- [Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction](https://scholariq.org/papers/hypertrophic-cardiomyopathy-with-left-ventricular-systolic-dysfunction/)
- [Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy](https://scholariq.org/papers/clinical-characteristics-and-outcomes-in-childhood-onset-hypertrophic/)

## Researcher topics

- [Cardiomyopathy and Myosin Studies](https://scholariq.org/topics/cardiomyopathy-and-myosin-studies/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiovascular Effects of Exercise](https://scholariq.org/topics/cardiovascular-effects-of-exercise/)
- [Congenital heart defects research](https://scholariq.org/topics/congenital-heart-defects-research/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.